Intravenous versus intrathecal dexmedetomidine as an additive to hyperbaric bupivacaine in spinal anesthesia for hip arthroplasty. A randomized controlled trial

MLA

Abdelrhman Alshawadfy, et al. “Intravenous versus Intrathecal Dexmedetomidine as an Additive to Hyperbaric Bupivacaine in Spinal Anesthesia for Hip Arthroplasty. A Randomized Controlled Trial.” Egyptian Journal of Anaesthesia, vol. 38, no. 1, Dec. 2022, pp. 342–48. EBSCOhost, https://doi.org/10.1080/11101849.2022.2085974.

APA

Abdelrhman Alshawadfy, Mohamed A. Elsadany, Amira Mahfouz Elkeblawy, & Ahmed A. El-Lilly. (2022). Intravenous versus intrathecal dexmedetomidine as an additive to hyperbaric bupivacaine in spinal anesthesia for hip arthroplasty. A randomized controlled trial. Egyptian Journal of Anaesthesia, 38(1), 342–348. https://doi.org/10.1080/11101849.2022.2085974

Chicago

Abdelrhman Alshawadfy, Mohamed A. Elsadany, Amira Mahfouz Elkeblawy, and Ahmed A. El-Lilly. 2022. “Intravenous versus Intrathecal Dexmedetomidine as an Additive to Hyperbaric Bupivacaine in Spinal Anesthesia for Hip Arthroplasty. A Randomized Controlled Trial.” Egyptian Journal of Anaesthesia 38 (1): 342–48. doi:10.1080/11101849.2022.2085974.